Home   |    Site Map   |    Copyright   |    Contact us   |    Privacy   |   
enzyme (lysozyme)

 
Enzymes
  Enzyme classes:
  EC 1: Oxidoreductases
  EC 2: Transferases
    EC 2.1
    EC 2.2
    EC 2.3
    EC 2.4
    EC 2.5
    EC 2.6
    EC 2.7
      EC 2.7.1
      EC 2.7.2
      EC 2.7.3
      EC 2.7.4
      EC 2.7.5
      EC 2.7.6
      EC 2.7.7
      EC 2.7.8
      EC 2.7.9
      EC 2.7.10
      EC 2.7.11
        EC 2.7.11.1
        EC 2.7.11.2
        EC 2.7.11.3
        EC 2.7.11.4
        EC 2.7.11.6
        EC 2.7.11.7
        EC 2.7.11.8
        EC 2.7.11.9
        EC 2.7.11.10
        EC 2.7.11.11
        EC 2.7.11.12
        EC 2.7.11.13
        EC 2.7.11.14
        EC 2.7.11.15
        EC 2.7.11.16
        EC 2.7.11.17
        EC 2.7.11.18
        EC 2.7.11.19
        EC 2.7.11.20
        EC 2.7.11.21
        EC 2.7.11.22
        EC 2.7.11.23
        EC 2.7.11.24
        EC 2.7.11.25
        EC 2.7.11.26
        EC 2.7.11.27
        EC 2.7.11.28
        EC 2.7.11.29
        EC 2.7.11.30
        EC 2.7.11.31
      EC 2.7.12
      EC 2.7.13
      EC 2.7.14
    EC 2.8
    EC 2.9
  EC 3: Hydrolases
  EC 4: Lyases
  EC 5: Isomerases
  EC 6: Ligases
  General information:
  Catalytic mechanism
  Enzyme kinetics
  Inhibitors
  Enzymes in industry

EC 2.7.11.22 - ATP:cyclin phosphotransferase (cyclin- dependent kinase)



3D structures of EC 2.7.11.22 - cyclin-dependent kinase in Protein Data Bank

updated: 29 May 2015, 1:12

In total: 277 PDB structures of EC 2.7.11.22 - cyclin-dependent kinase:
  1. 1fq1: Crystal Structure of Kinase Associated Phosphatase (kap) in Complex with Phospho-cdk2
  2. 3my5: Cdk2/cyclina in Complex with Drb
  3. 3my1: Structure of Cdk9/cyclint1 in Complex with Drb
  4. 3mtl: Crystal Structure of The Pctaire1 Kinase in Complex with Indirubin E804
  5. 3mia: Crystal Structure of Hiv-1 Tat Complexed with Atp-bound Human P-tefb
  6. 3mi9: Crystal Structure of Hiv-1 Tat Complexed with Human P-tefb
  7. 3lfs: Crystal Structure of Cdk2 with Sar37, an Aminoindazole Type Inhibitor
  8. 3lfq: Crystal Structure of Cdk2 with Sar60, an Aminoindazole Type Inhibitor
  9. 3lfn: Crystal Structure of Cdk2 with Sar57, an Aminoindazole Type Inhibitor
  10. 3le6: The Structure of Cyclin Dependent Kinase 2 (ckd2) with a Pyrazolobenzodiazepine Inhibitor
  11. 3igg: Novel Cdk-5 Inhibitors - Crystal Structure of Inhibitor Efq with Cdk-2
  12. 3ig7: Novel Cdk-5 Inhibitors - Crystal Structure of Inhibitor Efp with Cdk-2
  13. 3gbz: Structure of The Cmgc Cdk Kinase from Giardia Lamblia
  14. 3g33: Crystal Structure of Cdk4/cyclin D3
  15. 3fz1: Crystal Structure of a Benzthiophene Inhibitor Bound to Human Cyclin-dependent Kinase-2 (cdk-2)
  16. 3f5x: Cdk-2-cyclin Complex with Indazole Inhibitor 9 Bound at Its Active Site
  17. 3ezv: Cdk-2 with Indazole Inhibitor 9 Bound at Its Active Site
  18. 3ezr: Cdk-2 with Indazole Inhibitor 17 Bound at Its Active Site
  19. 3eoc: Cdk2/cyclina Complexed with a Imidazo Triazin-2-amine
  20. 3ej1: Cdk2/cyclina Complexed with a Pyrazolopyridazine Inhibitor
  21. 3eid: Cdk2/cyclina Complexed with a Pyrazolopyridazine Inhibitor
  22. 3dog: Structure of Thr 160 Phosphorylated Cdk2/cyclin a in Complex with The Inhibitor N-&-n1
  23. 3ddq: Structure of Phosphorylated Thr160 Cdk2/cyclin a in Complex with The Inhibitor Roscovitine
  24. 3ddp: Structure of Phosphorylated Thr160 Cdk2/cyclin a in Complex with The Inhibitor Cr8
  25. 3blr: Crystal Structure of Human Cdk9/cyclint1 in Complex with Flavopiridol
  26. 3blq: Crystal Structure of Human Cdk9/cyclint1 in Complex with Atp
  27. 3blh: Crystal Structure of Human Cdk9/cyclint1
  28. 3bhv: Structure of Phosphorylated Thr160 Cdk2/cyclin a in Complex with The Inhibitor Variolin B
  29. 3bhu: Structure of Phosphorylated Thr160 Cdk2/cyclin a in Complex with The Inhibitor Meriolin 5
  30. 3bht: Structure of Phosphorylated Thr160 Cdk2/cyclin a in Complex with The Inhibitor Meriolin 3
  31. 2xnb: Discovery and Characterisation of 2-anilino-4-(thiazol-5-yl) Pyrimidine Transcriptional Cdk Inhibitors as Anticancer Agents
  32. 2xmy: Discovery and Characterisation of 2-anilino-4-(thiazol-5-yl) Pyrimidine Transcriptional Cdk Inhibitors as Anticancer Agents
  33. 2wmb: Structural and Thermodynamic Consequences of Cyclization of Peptide Ligands for The Recruitment Site of Cyclin a
  34. 2wma: Structural and Thermodynamic Consequences of Cyclization of Peptide Ligands for The Recruitment Site of Cyclin a
  35. 2w9z: Crystal Structure of Cdk4 in Complex with a D-type Cyclin
  36. 2w9f: Crystal Structure of Cdk4 in Complex with a D-type Cyclin
  37. 2w99: Crystal Structure of Cdk4 in Complex with a D-type Cyclin
  38. 2w96: Crystal Structure of Cdk4 in Complex with a D-type Cyclin
  39. 2w17: Cdk2 in Complex with The Imidazole Pyrimidine Amide, Compound (s)-8b
  40. 2w06: Structure of Cdk2 in Complex with an Imidazolyl Pyrimidine, Compound 5c
  41. 2w05: Structure of Cdk2 in Complex with an Imidazolyl Pyrimidine, Compound 5b
  42. 2vv9: Cdk2 in Complex with an Imidazole Piperazine
  43. 2vu3: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  44. 2vtt: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  45. 2vts: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  46. 2vtr: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  47. 2vtq: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  48. 2vtp: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  49. 2vto: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  50. 2vtn: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  51. 2vtm: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  52. 2vtl: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  53. 2vtj: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  54. 2vti: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  55. 2vth: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design
  56. 2vta: Identification of N-(4-piperidinyl)-4-(2,6- Dichlorobenzoylamino)-1h-pyrazole-3-carboxamide (at7519), a Novel Cyclin Dependent Kinase Inhibitor Using Fragment- Based X-ray Crystallography and Structure Based Drug Design.
  57. 2v0d: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  58. 2uzo: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  59. 2uzn: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  60. 2uzl: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  61. 2uze: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  62. 2uzd: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  63. 2uzb: Crystal Structure of Human Cdk2 Complexed with a Thiazolidinone Inhibitor
  64. 2r64: Crystal Structure of a 3-aminoindazole Compound with Cdk2
  65. 2r3r: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  66. 2r3q: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  67. 2r3p: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  68. 2r3o: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  69. 2r3n: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  70. 2r3m: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  71. 2r3l: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  72. 2r3k: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  73. 2r3j: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  74. 2r3i: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  75. 2r3h: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  76. 2r3g: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  77. 2r3f: Crystal Structure of Cyclin-dependent Kinase 2 with Inhibitor
  78. 2qkr: Cryptosporidium Parvum Cyclin-dependent Kinase Cgd5_2510 with Indirubin 3'-monoxime Bound
  79. 2clx: 4-arylazo-3,5-diamino-1h-pyrazole Cdk Inhibitors: Sar Study, Crystal Structure in Complex with Cdk2, Selectivity, and Cellular Effects
  80. 2pmi: Structure of The Pho85-pho80 Cdk-cyclin Complex of The Phosphate-responsive Signal Transduction Pathway with Bound Atp-gamma-s
  81. 2pk9: Structure of The Pho85-pho80 Cdk-cyclin Complex of The Phosphate-responsive Signal Transduction Pathway
  82. 2ds1: Human Cyclin Dependent Kinase 2 Complexed with The Cdk4 Inhibitor
  83. 2duv: Structure of Cdk2 with a 3-hydroxychromones
  84. 2i40: Cdk2/cyclin a Complexed with a Thiophene Carboxamide Inhibitor
  85. 3ns9: Crystal Structure of Cdk2 in Complex with Inhibitor Bs-194
  86. 3lq5: Structure of Cdk9/cyclint in Complex with S-cr8
  87. 3nup: Cdk6 (monomeric) in Complex with Inhibitor
  88. 3nux: Cdk6 (monomeric) in Complex with Inhibitor
  89. 3o0g: Crystal Structure of Cdk5:p25 in Complex with an Atp Analogue
  90. 3pxf: Cdk2 in Complex with Two Molecules of 8-anilino-1-naphthalene Sulfonate
  91. 3pxq: Cdk2 in Complex with 3 Molecules of 8-anilino-1-naphthalene Sulfonate
  92. 3pxr: Apo Cdk2 Crystallized from Jeffamine
  93. 3pxy: Cdk2 in Complex with Inhibitor Jws648
  94. 3pxz: Cdk2 Ternary Complex with Jws648 and Ans
  95. 3py0: Cdk2 in Complex with Inhibitor Su9516
  96. 3py1: Cdk2 Ternary Complex with Su9516 and Ans
  97. 3pj8: Structure of Cdk2 in Complex with a Pyrazolo[4,3-d]pyrimidine Bioisostere of Roscovitine.
  98. 3qhr: Structure of a Pcdk2/cyclina Transition-state Mimic
  99. 3qhw: Structure of a Pcdk2/cyclina Transition-state Mimic
  100. 3s2p: Crystal Structure of Cdk2 with a 2-aminopyrimidine Compound
  101. 3rgf: Crystal Structure of Human Cdk8/cycc
  102. 4aaa: Crystal Structure of The Human Cdkl2 Kinase Domain
  103. 3unj: Cdk2 in Complex with Inhibitor Yl1-038-31
  104. 3unk: Cdk2 in Complex with Inhibitor Yl5-083
  105. 3tn8: Cdk9/cyclin T in Complex with Can508
  106. 3tnh: Cdk9/cyclin T in Complex with Can508
  107. 3tni: Structure of Cdk9/cyclin T F241L
  108. 3tnw: Structure of Cdk2/cyclin a in Complex with Can508
  109. 4acm: Cdk2 in Complex with 3-amino-6-(4-{[2-(dimethylamino)ethyl] Sulfamoyl}-phenyl)-n-pyridin-3-ylpyrazine-2-carboxamide
  110. 3sw4: Crystal Structure of The Cdk2 in Complex with Thiazolylpyrimidine Inhibitor
  111. 3sw7: Crystal Structure of The Cdk2 in Complex with Thiazolylpyrimidine Inhibitor
  112. 3ql8: Cdk2 in Complex with Inhibitor Jws-6-260
  113. 3qqf: Cdk2 in Complex with Inhibitor L1
  114. 3qqg: Cdk2 in Complex with Inhibitor L2-5
  115. 3qqh: Cdk2 in Complex with Inhibitor L2-2
  116. 3qqj: Cdk2 in Complex with Inhibitor L2
  117. 3qql: Cdk2 in Complex with Inhibitor L3
  118. 3qrt: Cdk2 in Complex with Inhibitor Nsk-mc2-55
  119. 3qru: Cdk2 in Complex with Inhibitor Nsk-mc1-12
  120. 3qwj: Cdk2 in Complex with Inhibitor Kvr-1-142
  121. 3qwk: Cdk2 in Complex with Inhibitor Kvr-1-150
  122. 3qx2: Cdk2 in Complex with Inhibitor Kvr-1-190
  123. 3qx4: Cdk2 in Complex with Inhibitor Kvr-1-78
  124. 3qxo: Cdk2 in Complex with Inhibitor Kvr-1-84
  125. 3qzf: Cdk2 in Complex with Inhibitor Jws-6-52
  126. 3qzg: Cdk2 in Complex with Inhibitor Jws-6-76
  127. 3qzh: Cdk2 in Complex with Inhibitor Kvr-1-124
  128. 3qzi: Cdk2 in Complex with Inhibitor Kvr-1-126
  129. 3r1q: Cdk2 in Complex with Inhibitor Kvr-1-102
  130. 3r1s: Cdk2 in Complex with Inhibitor Kvr-1-127
  131. 3r1y: Cdk2 in Complex with Inhibitor Kvr-1-134
  132. 3r28: Cdk2 in Complex with Inhibitor Kvr-1-140
  133. 3r6x: Cdk2 in Complex with Inhibitor Kvr-1-158
  134. 3r71: Cdk2 in Complex with Inhibitor Kvr-1-162
  135. 3r73: Cdk2 in Complex with Inhibitor Kvr-1-164
  136. 3r7e: Cdk2 in Complex with Inhibitor Kvr-1-67
  137. 3r7i: Cdk2 in Complex with Inhibitor Kvr-1-74
  138. 3r7u: Cdk2 in Complex with Inhibitor Kvr-1-75
  139. 3r7v: Cdk2 in Complex with Inhibitor Kvr-1-9
  140. 3r7y: Cdk2 in Complex with Inhibitor Kvr-2-88
  141. 3r83: Cdk2 in Complex with Inhibitor Kvr-2-92
  142. 3r8l: Cdk2 in Complex with Inhibitor L3-4
  143. 3r8m: Cdk2 in Complex with Inhibitor L3-3
  144. 3r8p: Cdk2 in Complex with Inhibitor Nsk-mc1-6
  145. 3rai: Cdk2 in Complex with Inhibitor Kvr-1-160
  146. 3rm6: Cdk2 in Complex with Inhibitor Kvr-2-80
  147. 3rm7: Cdk2 in Complex with Inhibitor Kvr-1-91
  148. 3roy: Cdk2 in Complex with Inhibitor Kvr-1-154
  149. 3rpo: Cdk2 in Complex with Inhibitor Kvr-1-156
  150. 3ti1: Cdk2 in Complex with Sunitinib
  151. 3tiy: Cdk2 in Complex with Nsc 35676
  152. 3tiz: Cdk2 in Complex with Nsc 111848
  153. 4erw: Cdk2 in Complex with Staurosporine
  154. 4ez3: Cdk2 in Complex with Nsc 134199
  155. 4ez7: Cdk2 in Complex with Staurosporine and 2 Molecules of 8-anilino-1- Naphthalene Sulfonic Acid
  156. 4ec8: Structure of Full Length Cdk9 in Complex with Cyclint and Drb
  157. 4ec9: Crystal Structure of Full-length Cdk9 in Complex with Cyclin T
  158. 4bbm: Crystal Structure of The Human Cdkl2 Kinase Domain with Bound Tcs 2312
  159. 3qqk: Cdk2 in Complex with Inhibitor L4
  160. 3qtq: Cdk2 in Complex with Inhibitor Rc-1-137
  161. 3qtr: Cdk2 in Complex with Inhibitor Rc-1-148
  162. 3qts: Cdk2 in Complex with Inhibitor Rc-2-12
  163. 3qtu: Cdk2 in Complex with Inhibitor Rc-2-132
  164. 3qtw: Cdk2 in Complex with Inhibitor Rc-2-13
  165. 3qtx: Cdk2 in Complex with Inhibitor Rc-2-35
  166. 3qtz: Cdk2 in Complex with Inhibitor Rc-2-36
  167. 3qu0: Cdk2 in Complex with Inhibitor Rc-2-38
  168. 3qxp: Cdk2 in Complex with Inhibitor Rc-3-89
  169. 3r8u: Cdk2 in Complex with Inhibitor Rc-1-132
  170. 3r8v: Cdk2 in Complex with Inhibitor Rc-1-135
  171. 3r8z: Cdk2 in Complex with Inhibitor Rc-1-136
  172. 3r9d: Cdk2 in Complex with Inhibitor Rc-2-135
  173. 3r9h: Cdk2 in Complex with Inhibitor Rc-2-142
  174. 3r9n: Cdk2 in Complex with Inhibitor Rc-2-21
  175. 3r9o: Cdk2 in Complex with Inhibitor Rc-2-143
  176. 3rah: Cdk2 in Complex with Inhibitor Rc-2-22
  177. 3rak: Cdk2 in Complex with Inhibitor Rc-2-32
  178. 3ral: Cdk2 in Complex with Inhibitor Rc-2-34
  179. 3rjc: Cdk2 in Complex with Inhibitor L4-12
  180. 3rk5: Cdk2 in Complex with Inhibitor Rc-2-72
  181. 3rk7: Cdk2 in Complex with Inhibitor Rc-2-71
  182. 3rk9: Cdk2 in Complex with Inhibitor Rc-2-74
  183. 3rkb: Cdk2 in Complex with Inhibitor Rc-2-73
  184. 3rmf: Cdk2 in Complex with Inhibitor Rc-2-33
  185. 3rni: Cdk2 in Complex with Inhibitor Rc-3-86
  186. 3rpr: Cdk2 in Complex with Inhibitor Rc-2-49
  187. 3rpv: Cdk2 in Complex with Inhibitor Rc-2-88
  188. 3rpy: Cdk2 in Complex with Inhibitor Rc-2-40
  189. 3rzb: Cdk2 in Complex with Inhibitor Rc-2-23
  190. 3s00: Cdk2 in Complex with Inhibitor L4-14
  191. 3s0o: Cdk2 in Complex with Inhibitor Rc-1-138
  192. 3s1h: Cdk2 in Complex with Inhibitor Rc-2-39
  193. 3sqq: Cdk2 in Complex with Inhibitor Rc-3-96
  194. 4gcj: Cdk2 in Complex with Inhibitor Rc-3-89
  195. 4aua: Liganded X-ray Crystal Structure of Cyclin Dependent Kinase 6 (cdk6)
  196. 4bcf: Structure of Cdk9 in Complex with Cyclin T and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  197. 4bch: Structure of Cdk9 in Complex with Cyclin T and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  198. 4bci: Structure of Cdk9 in Complex with Cyclin T and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  199. 4bcj: Structure of Cdk9 in Complex with Cyclin T and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  200. 4bco: Structure of Cdk2 in Complex with Cyclin a and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  201. 4bcq: Structure of Cdk2 in Complex with Cyclin a and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  202. 4eoi: Thr 160 Phosphorylated Cdk2 K89D, Q131E - Human Cyclin A3 Complex with The Inhibitor Ro3306
  203. 4eoj: Thr 160 Phosphorylated Cdk2 H84S, Q85M, K89D - Human Cyclin A3 Complex with Atp
  204. 4eok: Thr 160 Phosphorylated Cdk2 H84S, Q85M, K89D - Human Cyclin A3 Complex with The Inhibitor Nu6102
  205. 4eol: Thr 160 Phosphorylated Cdk2 H84S, Q85M, K89D - Human Cyclin A3 Complex with The Inhibitor Ro3306
  206. 4eom: Thr 160 Phosphorylated Cdk2 H84S, Q85M, Q131E - Human Cyclin A3 Complex with Atp
  207. 4eon: Thr 160 Phosphorylated Cdk2 H84S, Q85M, Q131E - Human Cyclin A3 Complex with The Inhibitor Ro3306
  208. 4eoo: Thr 160 Phosphorylated Cdk2 Q131E - Human Cyclin A3 Complex with Atp
  209. 4eop: Thr 160 Phosphorylated Cdk2 Q131E - Human Cyclin A3 Complex with The Inhibitor Ro3306
  210. 4eoq: Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex with Atp
  211. 4eor: Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex with The Inhibitor Nu6102
  212. 4eos: Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex with The Inhibitor Ro3306
  213. 4ez5: Cdk6 (monomeric) in Complex with Inhibitor
  214. 4i3z: Structure of Pcdk2/cyclina Bound to Adp and 2 Magnesium Ions
  215. 4ii5: Structure of Pcdk2/cyclina Bound to Adp and 1 Magnesium Ion
  216. 3zdu: Crystal Structure of The Human Cdkl3 Kinase Domain
  217. 4au8: Crystal Structure of Compound 4a in Complex with Cdk5, Showing an Unusual Binding Mode to The Hinge Region via a Water Molecule
  218. 4bcg: Structure of Cdk9 in Complex with Cyclin T and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  219. 4bck: Structure of Cdk2 in Complex with Cyclin a and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  220. 4bcm: Structure of Cdk2 in Complex with Cyclin a and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  221. 4bcn: Structure of Cdk2 in Complex with Cyclin a and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  222. 4bcp: Structure of Cdk2 in Complex with Cyclin a and a 2-amino-4- Heteroaryl-pyrimidine Inhibitor
  223. 4imy: The Aff4 Scaffold Binds Human P-tefb Adjacent to Hiv Tat
  224. 4bgq: Crystal Structure of The Human Cdkl5 Kinase Domain
  225. 4ek3: Crystal Structure of Apo Cdk2
  226. 4ek4: Crystal Structure of The Cdk2 in Complex with Aminopyrazole Inhibitor
  227. 4ek5: Crystal Structure of The Cdk2 in Complex with Aminopyrazole Inhibitor
  228. 4ek6: Crystal Structure of The Cdk2 in Complex with Aminopyrazole Inhibitor
  229. 4ek8: Crystal Structure of The Cdk2 in Complex with Thiazolylpyrimidine Inhibitor
  230. 4f6s: Crystal Structure of Human Cdk8/cycc in Complex with Compound 7 (1-[3- Tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]urea)
  231. 4f6u: Crystal Structure of Human Cdk8/cycc in Complex with Compound 5 (1-[3- Tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-[3-(morpholin-4-yl) Propyl]urea)
  232. 4f6w: Crystal Structure of Human Cdk8/cycc in Complex with Compound 1 (n-[3- Tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-4-[2-({[3-tert-butyl- 1-(4-methylphenyl)-1h-pyrazol-5-yl]carbamoyl}amino)ethyl]piperazine- 1-carboxamide)
  233. 4f70: Crystal Structure of Human Cdk8/cycc in Complex with Compound 4 (1-[3- Tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-[2-(morpholin-4-yl) Ethyl]urea)
  234. 4f7j: Crystal Structure of Human Cdk8/cycc in Complex with Compound 3 (1-[3- Tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-(2-hydroxyethyl) Urea)
  235. 4f7l: Crystal Structure of Human Cdk8/cycc in Complex with Compound 2 (tert- Butyl [3-({[3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5- Yl]carbamoyl}amino)propyl]carbamate)
  236. 4f7n: Crystal Structure of Human Cdk8/cycc in Complex with Compound 11 (1- [3-tert-butyl-1-(4-methylphenyl)-1h-pyrazol-5-yl]-3-(5- Hydroxypentyl)urea)
  237. 4f7s: Crystal Structure of Human Cdk8/cycc in The Dmg-in Conformation
  238. 4fkg: Crystal Structure of The Cdk2 in Complex with Aminopyrazole Inhibitor
  239. 4fki: Crystal Structure of The Cdk2 in Complex with Aminopyrazole Inhibitor
  240. 4fkj: Crystal Structure of The Cdk2 in Complex with Aminopyrazole Inhibitor
  241. 4fkl: Crystal Structure of The Cdk2 in Complex with Thiazolylpyrimidine Inhibitor
  242. 4fko: Crystal Structure of The Cdk2 in Complex with Thiazolylpyrimidine Inhibitor
  243. 4fkp: Crystal Structure of The Cdk2 in Complex with Oxindole Inhibitor
  244. 4fkq: Crystal Structure of The Cdk2 in Complex with Oxindole Inhibitor
  245. 4fkr: Crystal Structure of The Cdk2 in Complex with Oxindole Inhibitor
  246. 4fks: Crystal Structure of The Cdk2 in Complex with Oxindole Inhibitor
  247. 4fkt: Crystal Structure of The Cdk2 in Complex with Oxindole Inhibitor
  248. 4fku: Crystal Structure of The Cdk2 in Complex with Oxindole Inhibitor
  249. 4fkv: Crystal Structure of The Cdk2 in Complex with Oxindole Inhibitor
  250. 4fkw: Crystal Structure of The Cdk2 in Complex with Oxindole Inhibitor
  251. 4g6l: Crystal Structure of Human Cdk8/cycc in The Dmg-in Conformation
  252. 4fx3: Crystal Structure of The Cdk2/cyclin a Complex with Oxindole Inhibitor
  253. 3uli: Human Cyclin Dependent Kinase 2 (cdk2) Bound to Azabenzimidazole Derivative
  254. 3wbl: Crystal Structure of Cdk2 in Complex with Pyrazolopyrimidine Inhibitor
  255. 4bgh: Crystal Structure of Cdk2 in Complex with Pan-cdk Inhibitor
  256. 4bzd: Structure of Cdk2 in Complex with a Benzimidazopyrimidine
  257. 4cfn: Structure-based Design of C8-substituted O6-cyclohexylmethoxyguanine Cdk1 and 2 Inhibitors.
  258. 4cfw: Structure-based Design of C8-substituted O6- Cyclohexylmethoxyguanine Cdk1 and 2 Inhibitors.
  259. 4cxa: Crystal Structure of The Human Cdk12-cyclin K Complex Bound to Amppnp
  260. 4kd1: Cdk2 in Complex with Dinaciclib
  261. 4krc: Crystal Structure of Pho85-pcl10-atp-gamma-s Complex
  262. 4krd: Crystal Structure of Pho85-pcl10 Complex
  263. 4lyn: Crystal Structure of Cyclin-dependent Kinase 2 (cdk2-wt) Complex with (2s)-n-(5-(((5-tert-butyl-1,3-oxazol-2-yl)methyl)sulfanyl)-1,3- Thiazol-2-yl)-2-phenylpropanamide
  264. 4nj3: Modulating The Interaction between Cdk2 and Cyclin a with a Quinoline- Based Inhibitor
  265. 4nst: Crystal Structure of Human Cdk12/cyclin K in Complex with Adp-aluminum Fluoride
  266. 4ogr: Crystal Structure of P-tefb Complex with Aff4 and Tat
  267. 4or5: Crystal Structure of Hiv-1 Tat Complexed with Human P-tefb and Aff4
  268. 4tth: Crystal Structure of a Cdk6/vcyclin Complex with Inhibitor Bound
  269. 4un0: Crystal Structure of The Human Cdk12-cyclink Complex
  270. 4rj3: Cdk2 with Egfr Inhibitor Compound 8
  271. 4cfm: Structure-based Design of C8-substituted O6- Cyclohexylmethoxyguanine Cdk1 and 2 Inhibitors.
  272. 4cfu: Structure-based Design of C8-substituted O6- Cyclohexylmethoxyguanine Cdk1 and 2 Inhibitors.
  273. 4cfv: Structure-based Design of C8-substituted O6- Cyclohexylmethoxyguanine Cdk1 and 2 Inhibitors.
  274. 4cfx: Structure-based Design of C8-substituted O6-cyclohexylmethoxyguanine Cdk1 and 2 Inhibitors.
  275. 4d1x: Cdk2 in Complex with Luciferin
  276. 4d1z: Cdk2 in Complex with a Luciferin Derivate
  277. 4yc6: Cdk1/cks1
© Copyright 2008-2009 by enzymes.me.uk